Abstract
The pathophysiology and etiology of schizophrenia have been the subjects of extensive research during the last decade. The results of family-, twin-, and adoption-studies strongly indicate that genetic factors are of etiological importance in a number of cases (Slater and Cowie, 1971; Kety, et al., 1975). The therapeutic effect of neuroleptic drugs in schizophrenia and the possibility to induce schizophrenia-like psychosis by chemical compounds like LSD and amphetamine stimulated pharmacologists to analyze the mechanism of action of these drugs in the brain. Such an approach might give a clue to the pathophysiological mechanisms responsible for the manifestation of psychosis. Subsequent research demonstrated that neuroleptic and hallucinogenic compounds specifically interfere with the monoaminergic mechanisms in the brain (Matthysse and Lipinski, 1975; Carlsson, 1978). Therefore, the possible occurrence of disturbances in the central monoaminergic mechanisms in schizophrenia has been proposed by a number of scientists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D. F., MacDougall, E. J., Stanton, J. B., Binns, J. K., 1966, Lancet, 2: 1049–1050.
Bowers, M. B., 1974, Arch. Gen. Psychiat., 31: 50–54.
Carlsson, A., 1978, Am. J. Psychiat., 135: 164–173.
Kety, S. S., Rosenthal, D., Wender, P. H., Schulsinger, F., Jacobsen, B., in: “Genetic Research in Psychiatry,” R. Fieve, D. Rosenthal, and H. Brill, Eds., The John Hopkins University Press, Baltimore and London, 1975, pp. 147–165.
Matthysse, S., Lipinski, J., 1975, Ann. Rev. Med., 26: 551–565.
Murphy, D. L., Wyatt, R. J., 1972, Nature, 238: 225–226.
Muskiet, F. A. J., Jeuring, H. J., Korf, J., Sedvall, G., Westerink, B. H. C., Teelken, A. W., Wolthers, B. G., 1979, J. Neurochem., 32: 191–194.
Persson, T., Roos, B.-E, 1969, Br. J. Psychiat., 115: 95–98.
Post, R. M., Fink, E., Carpenter, W. T., Goodwin, F. K., 1975, Arch. Gen. Psychiat., 32: 1063–1969.
Sedvall, G., Fyrö, B., Gullberg, B., Nyback, H. Wiesel, F.-A., Wode-Helgodt, B., 1980, Br. J. Psychiat., 136: 366–374.
Sedvall, G., Wode-Helgodt, B., 1980, Arch. Gen. Psychiat., 37: 1113–1116.
Slater, E., Cowie, V. A., 1971, “The Genetics of Mental Disorders,” University Oxford Press, London.
Swahn, C.-G., Sandgärde, B. Wiesel, F.-A., Sedvall, G., 1976, Psychopharmacology, 48: 147–152.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Press, New York
About this chapter
Cite this chapter
Sedvall, G. (1981). Serotonin Metabolite Concentrations in Cerebrospinal Fluid from Schizophrenic Patients—Relationships to Family History. In: Haber, B., Gabay, S., Issidorides, M.R., Alivisatos, S.G.A. (eds) Serotonin. Advances in Experimental Medicine and Biology, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3860-4_39
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3860-4_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3862-8
Online ISBN: 978-1-4684-3860-4
eBook Packages: Springer Book Archive